Role of autologous bone marrow transplant in multiple myeloma.

Autores de IIS La Fe

• Marino Blanes Juliá

  Autor

• 

  Javier De La Rubia Comos

  Autor

Grupos

• Hematología y Hemoterapia

Abstract

The treatment of newly diagnosed multiple myeloma has evolved rapidly over the recent years. In younger patients, autologous stem cell transplantation (ASCT) is still considered the standard of care, but the availability of new effective drugs with novel mechanisms of action in the last decade has resulted in a new scenario that has caused the role of transplantation itself to be currently undergoing scrutiny.